-
Pfizer Tanks on Earnings, Unhealthy Guidance
Tuesday, April 30, 2013 - 10:36am | 446Read More...Pfizer (NYSE: PFE) is down Tuesday after reporting woeful first-quarter earnings and lowering its guidance. The New York City-based firm's EPS rose 58 percent to $0.38, but fell far short of the $0.56 Wall Street consensus. Revenue fell over nine percent to $13.5 billion, missing the $14...
-
FDA Approves Pfizer (NYSE: PFE) Prevnar 13 Bacteria Vaccine
Wednesday, February 24, 2010 - 1:48pm | 101Read More...The U.S. Food and Drug Administration approved the Pfizer Inc. (NYSE: PFE) vaccine Prevnar 13 as a follow up vaccine of Prevnar. The vaccines protect children from the age of 6 weeks to 5 years old from bacteria that can cause serious illnesses, such as as meningitis, acute ear infections,...
